The US Preventive Services Task Force now recommends against prostate-specific antigen (PSA)-based screening for prostate cancer, citing potential for "overdiagnosis." This development highlights the benefits of utilizing functional assessments to provide additional information about risk and inform the use of therapeutics that can positively impact prostate health. In this webinar, a summary of the latest developments in men's hormonal health will be provided along with case studies and practical clinical tools.
- Discuss testing considerations for all men, including those on hormone therapy
- Highlight key pathways in androgen and estrogen metabolism that are involved in disease risk
- Provide an overview of therapeutic strategies that influence hormone metabolism
Keywords: prostate cancer – prostate health – prostate-specific antigen (PSA)
Warren Brown, ND
Warren Brown, ND, earned his doctorate degree from the School of Naturopathic Medicine at Bastyr University in Seattle, Washington. He went on to complete an 18-month residency program in the fields of primary care and family medicine at the Holistic Health Clinic in Tacoma, Washington.
In addition to private practice, Dr. Brown has held various teaching, speaking, and writing roles - experience which he brings to the medical education team at Genova Diagnostics.
Dr. Brown enjoys working with practitioners from all medical disciplines and providing the support needed to help improve clinical outcomes.